ArticleBioMed research international2019

Treatment with Molgramostim (Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor, Rhugm-Csf, Mielogen) and Lenograstim (Granulocyte-Colony Stimulating Factor) Improves Experimental Colitis in Rats.

Apostolos E Papalois et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.